Skip to main content
Clinical Trials/EUCTR2005-001315-22-AT
EUCTR2005-001315-22-ATActive, not recruitingNot Applicable

The effect of the cholinesterase inhibitor donepezil on organic and functional deficits related to growth hormone deficiency in old age.

udwig Boltzmann Gesellschaft0 sites80 target enrollmentStarted: January 18, 2006Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
80

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Healthy aging women and men aged 70 to 75 years.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • Sick sinus syndrome, atrioventricular block, sinuatrial block
  • Asthma brochiale, COPD
  • Gastric or duodenal ulcers
  • Urinary obstruction
  • Severe renal or hepatic impairment
  • Known hypersensitivity against the investigational drug
  • Medication with beta-blockers, cholinomemetica or NSAIDs

Investigators

Sponsor
udwig Boltzmann Gesellschaft

Similar Trials